ATE99955T1 - Als anti-malaria-impfstoff verwendbares immunologisch aktives peptidkonjugat ppd-(nanp)n. - Google Patents

Als anti-malaria-impfstoff verwendbares immunologisch aktives peptidkonjugat ppd-(nanp)n.

Info

Publication number
ATE99955T1
ATE99955T1 AT89201985T AT89201985T ATE99955T1 AT E99955 T1 ATE99955 T1 AT E99955T1 AT 89201985 T AT89201985 T AT 89201985T AT 89201985 T AT89201985 T AT 89201985T AT E99955 T1 ATE99955 T1 AT E99955T1
Authority
AT
Austria
Prior art keywords
conjugate
ppd
peptide conjugate
immunologically active
active peptide
Prior art date
Application number
AT89201985T
Other languages
English (en)
Inventor
Antonio Silvio Verdini
Antonello Pessi
Giudice Giuseppe Del
Paul Henry Lambert
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Application granted granted Critical
Publication of ATE99955T1 publication Critical patent/ATE99955T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT89201985T 1988-08-05 1989-07-28 Als anti-malaria-impfstoff verwendbares immunologisch aktives peptidkonjugat ppd-(nanp)n. ATE99955T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8821666A IT1226728B (it) 1988-08-05 1988-08-05 Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
EP89201985A EP0353823B1 (de) 1988-08-05 1989-07-28 Als Anti-Malaria-Impfstoff verwendbares immunologisch aktives Peptidkonjugat PPD-(NANP)n

Publications (1)

Publication Number Publication Date
ATE99955T1 true ATE99955T1 (de) 1994-01-15

Family

ID=11185073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89201985T ATE99955T1 (de) 1988-08-05 1989-07-28 Als anti-malaria-impfstoff verwendbares immunologisch aktives peptidkonjugat ppd-(nanp)n.

Country Status (5)

Country Link
EP (1) EP0353823B1 (de)
AT (1) ATE99955T1 (de)
DE (1) DE68912229T2 (de)
ES (1) ES2061944T3 (de)
IT (1) IT1226728B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
AU7282498A (en) * 1997-05-01 1998-11-24 Emory University Bioactive peptides derived from cocaine and amphetamine regulated transcript protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849551A (en) * 1972-09-28 1974-11-19 Antonio L D Bcg as adjuvant in malaria vaccination
WO1985000975A1 (en) * 1983-08-19 1985-03-14 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
ES8800273A1 (es) * 1985-03-28 1987-11-01 Univ New York Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche

Also Published As

Publication number Publication date
EP0353823B1 (de) 1994-01-12
IT1226728B (it) 1991-02-05
IT8821666A0 (it) 1988-08-05
DE68912229D1 (de) 1994-02-24
DE68912229T2 (de) 1994-05-19
EP0353823A1 (de) 1990-02-07
ES2061944T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
Nunberg et al. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.
EP0283505B1 (de) Impfstoff und verfahren zur herstellung
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
DK0578293T3 (da) E. coli-P-fimbrin som immunogent bæresystem mod GnRH
FI905441A0 (fi) Rekombinanta flagellinvacciner.
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
Audibert et al. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
ATE99955T1 (de) Als anti-malaria-impfstoff verwendbares immunologisch aktives peptidkonjugat ppd-(nanp)n.
US4584195A (en) Broad spectrum vaccine against gonorrhea
Clough et al. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative
EP0270295A3 (de) Konjugat-Impfstoff
ES2079851T3 (es) Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas.
EP0282501A1 (de) Regulierung der tierreproduktion
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
ATE175357T1 (de) Empfängnisverhütender impfstoff
AU613588C (en) Vaccine and method of preparation
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
Mukerjee et al. Effect of adjuvants on immunization with dengue virus-induced cytotoxic factor
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств
Jolivet et al. INCREASED ADJUVANT ACTIVITY OF MDP BY DIRECT COUPLING OF MDP TO THE IMMUNOGEN
GR1001220B (el) Φορεις κυτοκινης και ορμονης για συζευγμενα εμβολια.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee